These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10368685)

  • 1. Antiproliferative and cytotoxic effects of N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with anthracycline(s), anthraquinone and nitroxides action.
    Metodiewa D; Koceva-Chyła A; Kochman A; Skolimowski J; Jóźwiak Z
    Anticancer Res; 1999; 19(2A):1255-60. PubMed ID: 10368685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer potential of N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with mitoxantrone action on rat Yoshida sarcoma cells in vivo.
    Metodiewa D; Kochman A; Koceva-Chyła A
    Anticancer Res; 1999; 19(2A):1249-54. PubMed ID: 10368684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tempicol-3, a novel piperidine-N-oxide stable radical and antioxidant, with low toxicity acts as apoptosis inducer and cell proliferation modifier of Yoshida Sarcoma cells in vivo.
    Koceva-Chyła A; Kochman A; Głebska J; Gwoździnski K; Jóźwiak Z; Metodiewa D
    Anticancer Res; 2000; 20(6B):4611-8. PubMed ID: 11205311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TTT, a novel free radical spin trap, induces apoptosis in sarcoma Yoshida cells in vivo: comparative investigations of its cytotoxicity in vitro.
    Metodiewa D; Kochman A; Skolimowski J; Koceva-Chyła A
    Anticancer Res; 1999; 19(4B):3343-8. PubMed ID: 10652631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
    Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
    Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of low-power laser irradiation and anthraquinone anticancer drug aclarubicin on survival of immortalized cells: Comparison with mitoxantrone.
    Koceva-Chyła A; Wiecławska B; Jóźwiak Z; Bryszewska M
    Cell Biol Int; 2006 Aug; 30(8):645-52. PubMed ID: 16857396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradoxical apoptotic effects of novel nitroxide antioxidants on Yoshida sarcoma cells in vivo: a commentary.
    Metodiewa D; Skolimowski J; Kochman A; Koceva-Chyla A
    Anticancer Res; 2000; 20(4):2593-9. PubMed ID: 10953331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for peroxidative oxidation of substituted piperidine nitroxides, acting as apoptosis inducers in Yoshida Sarcoma cells in vivo.
    Metodiewa D; Kochman A; Gebicka L; Skolimowski J
    Anticancer Res; 2000; 20(4):2421-6. PubMed ID: 10953305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tempicol-2 (4-hydroxy-4-(2-picolyl)-2,2,6,6-tetramethylpiperidine-1-oxyl), a stable free radical, is a novel member of nitroxide class of antioxidants and anticancer agents.
    Metodiewa D; Skolimowski J; Kochman A; Gwozdzinski K; Głebska J
    Anticancer Res; 1998; 18(1A):369-77. PubMed ID: 9568105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiproliferative activity of some androstene oximes and their O-alkylated derivatives.
    Acharya PC; Bansal R
    Arch Pharm (Weinheim); 2014 Mar; 347(3):193-9. PubMed ID: 24343881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of N,N-diethylaminoethyl ethers of flavanone oximes and the study of their antihistaminic and spasmolytic properties].
    Królikowska M; Perka W; Szadowska A; Wejman I
    Acta Pol Pharm; 1979; 36(6):667-71. PubMed ID: 45069
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes.
    Shanab K; Pongprom N; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6091-5. PubMed ID: 17904839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
    Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
    Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
    Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
    Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
    Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
    Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antiproliferative activity and inhibition of tubulin polymerization by anthracenone-based oxime derivatives.
    Surkau G; Böhm KJ; Müller K; Prinz H
    Eur J Med Chem; 2010 Aug; 45(8):3354-64. PubMed ID: 20546980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between structure and antioxidative activity of piperidine nitroxides.
    Li WG; Zhang XY; Wu YJ; Gao MT; Zheng RL
    J Pharm Pharmacol; 2006 Jul; 58(7):941-9. PubMed ID: 16805954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.